Abbott Boosts Diabetes Unit through Acquisition of TheraSense

By Business Review Editor

Pharma Deals Review: Vol 2004 Issue 45 (Table of Contents)

Published: 4 Mar-2004

DOI: 10.3833/pdr.v2004.i45.826     ISSN: 1756-7874

Section: Mergers & Acquisitions

Fulltext:

Abstract

Abbott Laboratories acquires diabetes products maker TheraSense for US$1...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details